Robert Daniel Rosenberg, Ph.D., M.D.
This page shows the publications co-authored by Robert Rosenberg and Keiichi Enjyoji.
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 1999 Sep; 5(9):1010-7.
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signal. 2011 Jun; 7(2):231-41.
Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J Clin Invest. 2003 Apr; 111(7):989-99.
CD39/vascular ATP diphosphohydrolase modulates xenograft survival. Transplant Proc. 2000 Aug; 32(5):969.
Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. Mol Med. 1999 Nov; 5(11):743-52.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.